Pharmacokinetics and radiation dosimetry of 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11C-FMAU) in humans.

被引:0
|
作者
Bading, JR [1 ]
Alauddin, MM [1 ]
Shahinian, AH [1 ]
Conti, PS [1 ]
机构
[1] Univ So Calif, Los Angeles, CA USA
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
1075
引用
收藏
页码:266P / 266P
页数:1
相关论文
共 50 条
  • [1] Tumor imaging with 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11C-FMAU):: Initial clinical studies.
    Conti, PS
    Bading, JR
    Alauddin, MM
    Fissekis, JD
    Berenji, B
    Hayles, S
    Jadvar, H
    JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) : 26P - 26P
  • [2] Pharmacokinetics of 2'-fluoro-5-[11C]-methyl-1-β-D-arabinofuranosyluracil ([11C]FMAU) in monkeys.
    Bading, JR
    Alauddin, MM
    Fissekis, JD
    Kirkman, E
    Vail, A
    Conti, PS
    JOURNAL OF NUCLEAR MEDICINE, 2000, 41 (05) : 234P - 234P
  • [3] Pet imaging of 2′-fluoro-5-11C-methyl-1-β-D-arabinofuranosyluracil (11CFMAU) indicates brain tumor growth rate in dogs.
    Conti, PS
    Bading, JR
    Mouton, P
    Links, JM
    Alauddin, MM
    Wong, DF
    Ravert, HT
    Hilton, J
    Anderson, JH
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 83P - 83P
  • [4] Pharmacokinetics of the thymidine analog 2′-fluoro-5-methyl-1-β-D-arabinofuranosyluracil (FMAU) in tumor-bearing rats
    Bading, JR
    Shahinian, AH
    Vail, A
    Bathija, P
    Koszalka, GW
    Koda, RT
    Alauddin, MM
    Fissekis, JD
    Conti, PS
    NUCLEAR MEDICINE AND BIOLOGY, 2004, 31 (04) : 407 - 418
  • [5] Pharmacokinetics of the thymidine analog 2′-fluoro-5-[14C]-methyl-1-β-D-arabinofuranosyluracil ([14C]FMAU) in rat prostate tumor cells
    Bading, JR
    Shahinian, AH
    Bathija, P
    Conti, PS
    NUCLEAR MEDICINE AND BIOLOGY, 2000, 27 (04) : 361 - 368
  • [6] SYNTHESIS OF 2'-FLUORO-5-[C-11-METHYL]-1-BETA-D-ARABINOFURANOSYLURACIL (C-11-FMAU) FOR USE IN IN-VIVO IMAGING BY POSITRON EMISSION TOMOGRAPHY (PET)
    ALAUDDIN, MM
    FISSEKIS, JR
    CONTI, PS
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 45 - NUCL
  • [7] Synthesis of F-18 2-fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([F-18]FMAU).
    Conti, PS
    Alauddin, MM
    Fissekis, JD
    Watanabe, KA
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 83P - 83P
  • [8] SYNTHESIS OF 2'-FLUORO-5-[C-11]-METHYL-1-BETA-D-ARABINOFURANOSYLURACIL ([C-11]-FMAU) - A POTENTIAL NUCLEOSIDE ANALOG FOR IN-VIVO STUDY OF CELLULAR PROLIFERATION WITH PET
    CONTI, PS
    ALAUDDIN, MM
    FISSEKIS, JR
    SCHMALL, B
    WATANABE, KA
    NUCLEAR MEDICINE AND BIOLOGY, 1995, 22 (06) : 783 - 789
  • [9] Radiation dosimetry of L-[1-11C]-Tyrosine in humans.
    Pool, L
    Jager, PL
    Pruim, J
    Vaalburg, W
    Paans, A
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 322P - 322P
  • [10] SELECTIVE ALKYLATION SUITABLE FOR LABELING THE ANTIVIRAL AGENT 2'-FLUORO-5-METHYL-1-BETA-D-ARABINOFURANOSYLURACIL(FMAU) WITH C-11 FOR USE IN INVIVO IMAGING
    SUNDOROWU, BM
    SCHMALL, B
    CONTI, PS
    WATANABE, KA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1984, 187 (APR): : 14 - ORGN